Inari Medical to Announce First Quarter 2022 Financial Results
April 20, 2022 16:01 ET
|
Inari Medical, Inc.
IRVINE, Calif., April 20, 2022 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a medical device company with a mission to treat and transform the lives of patients suffering from...
Inari Medical Announces Closing of Underwriters’ Over-Allotment Option in Connection with Offering of Common Stock
March 21, 2022 17:27 ET
|
Inari Medical, Inc.
IRVINE, Calif., March 21, 2022 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a medical device company with a mission to treat and transform the lives of patients suffering from...
Inari Medical Announces Pricing of Offering of Common Stock
March 10, 2022 21:07 ET
|
Inari Medical, Inc.
IRVINE, Calif., March 10, 2022 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a medical device company focused on developing products to treat and transform the lives of patients...
Inari Medical Announces Proposed Offering of Common Stock
March 10, 2022 07:33 ET
|
Inari Medical, Inc.
IRVINE, Calif., March 10, 2022 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a medical device company focused on developing products to treat and transform the lives of patients...
Inari Medical Appoints Robert Warner to Board of Directors
March 01, 2022 08:00 ET
|
Inari Medical, Inc.
IRVINE, Calif., March 01, 2022 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”) a medical device company with a mission to treat and transform the lives of patients suffering from...
Inari Medical Reports Fourth Quarter and Full Year 2021 Financial Results
February 23, 2022 16:01 ET
|
Inari Medical, Inc.
IRVINE, Calif., Feb. 23, 2022 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a medical device company with a mission to treat and transform the lives of patients suffering from...
Inari Medical Announces First Patient Enrolled in the PEERLESS Trial, a Randomized Controlled Trial Evaluating Outcomes of the FlowTriever® System in Pulmonary Embolism Patients
February 15, 2022 08:00 ET
|
Inari Medical, Inc.
IRVINE, Calif., Feb. 15, 2022 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”) today announced that the first patient has been enrolled in PEERLESS, a prospective, randomized...
Inari Medical to Announce Fourth Quarter and Full-Year 2021 Financial Results
February 10, 2022 16:01 ET
|
Inari Medical, Inc.
IRVINE, Calif., Feb. 10, 2022 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a medical device company focused on developing products to treat and transform the lives of patients...
Inari Medical to Present at Upcoming Investor Conferences
February 01, 2022 16:01 ET
|
Inari Medical, Inc.
IRVINE, Calif., Feb. 01, 2022 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a medical device company focused on developing products to treat and transform the lives of patients...
Inari Medical Reports Preliminary Fourth Quarter 2021 Revenue
January 10, 2022 16:01 ET
|
Inari Medical, Inc.
IRVINE, Calif., Jan. 10, 2022 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a medical device company focused on developing products to treat and transform the lives of patients...